Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Alpha Cognition Inc (ACOG)

Alpha Cognition Inc (ACOG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners Business Wire - Mon Dec 1, 4:51PM CST

Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced...

ACOG : 6.37 (+9.64%)
Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update Business Wire - Thu Nov 13, 3:00PM CST

Key Highlights ZUNVEYL Launch Momentum: Completed the second quarter of commercialization, generating approximately $2.8 million...

ACOG : 6.37 (+9.64%)
Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025 Business Wire - Thu Oct 30, 7:30AM CDT

Management to host conference call on Thursday, November 13, 2025 at 4:30pm ET

ACOG : 6.37 (+9.64%)
Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025 Business Wire - Thu Oct 30, 7:30AM CDT

Management to host conference call on Thursday, November 13, 2025 at 4:30pm ET

ACOG : 6.37 (+9.64%)
Alpha Cognition to Present Clinical Data at Consultant Pharmacy and Neuroscience Education Institute Meetings Business Wire - Tue Oct 14, 3:30PM CDT

Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced...

ACOG : 6.37 (+9.64%)
Alpha Cognition to Present Clinical Data at ASCP Annual Meeting Business Wire - Mon Oct 6, 7:30AM CDT

Alpha Cognition Inc. (Nasdaq: ACOG), a commercial-stage biopharmaceutical company developing therapies for neurodegenerative diseases, today announced it will present new clinical insights on cholinesterase...

ACOG : 6.37 (+9.64%)
Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares Business Wire - Tue Sep 30, 10:14PM CDT

Offering was led by an initial investment from a premier healthcare-dedicated investor alongside multiple large existing shareholders Company’s total cash position expected...

ACOG : 6.37 (+9.64%)
Alpha Cognition Inc. Announces Proposed Public Offering of Common Shares Business Wire - Tue Sep 30, 3:58PM CDT

Alpha Cognition Inc. (Nasdaq: ACOG) (the “Company”), a commercial-stage biopharmaceutical company dedicated to developing innovative treatments for neurodegenerative diseases, today announced that...

ACOG : 6.37 (+9.64%)
Alpha Cognition Inc. (Nasdaq: ACOG) Announces Participation in Key September Investor Conferences Business Wire - Thu Aug 28, 12:00PM CDT

Alpha Cognition Inc. (Nasdaq: ACOG), a commercial-stage biopharmaceutical company dedicated to developing innovative treatments for neurodegenerative diseases, today announced that Chief Executive Officer...

ACOG : 6.37 (+9.64%)
Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update Business Wire - Thu Aug 14, 7:30AM CDT

Key Highlights ZUNVEYL Launch Momentum: Completed the first quarter of ZUNVEYL commercialization, achieving approximately...

ACOG : 6.37 (+9.64%)

Barchart Exclusives

Michael Burry Doubles Down on Molina Healthcare Stock. What Is the Bull Case for MOH Here? Barchart - 6 minutes ago
Burry finds value in holding this healthcare counter for the long term. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot